Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 1, Open-Label, Dose Escalation, Safety, and Tolerability Study of INCB054828 in Subjects with Advanced Malignancies
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.